Help Privacy Policy Disclaimer
  Advanced SearchBrowse




Journal Article

Evidence for competition for target innervation in the medial prefrontal cortex


Sipilä,  Pia
Max Planck Research Group: Circuits for Emotion / Gogolla, MPI of Neurobiology, Max Planck Society;

External Resource
No external resources are shared
Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)
Supplementary Material (public)
There is no public supplementary material available

Guirado, R., Umemori, J., Sipilä, P., & Castren, E. (2016). Evidence for competition for target innervation in the medial prefrontal cortex. Cerebral Cortex, 26(3), 1287-1294. doi:10.1093/cercor/bhv280.

Cite as: https://hdl.handle.net/11858/00-001M-0000-002A-240B-9
Inputs to sensory cortices are known to compete for target innervation through an activity-dependent mechanism during critical periods. To investigate whether this principle also applies to association cortices such as the medial prefrontal cortex (mPFC), we produced a bilateral lesion during early development to the ventral hippocampus (vHC), an input to the mPFC, and analyzed the intensity of the projection from another input, the basolateral amgydala (BLA). We found that axons from the BLA had a higher density of "en passant" boutons in the mPFC of lesioned animals. Furthermore, the density of neurons labeled with retrograde tracers was increased, and neurons projecting from the BLA to the mPFC showed increased expression of FosB. Since neonatal ventral hippocampal lesion has been used as an animal model of schizophrenia, we investigated its effects on behavior and found a negative correlation between the density of retrogradely labeled neurons in the BLA and the reduction of the startle response in the prepulse inhibition test. Our results not only indicate that the inputs from the BLA and the vHC compete for target innervation in the mPFC during postnatal development but also that subsequent abnormal rewiring might underlie the pathophysiology of neuropsychiatric disorders such as schizophrenia.